In asthma patients, elevated levels of airway and blood eosinophils as well as IL-5 have been demonstrated in multiple studies and are considered to be a hallmark of certain asthma phenotypes, particularly those unresponsive or refractory to ICS, making them appealing therapeutic targets [31]. This evidence concerns the gene IL5 and asthma.